What is the Impact Factor of Cancer Genomics & Proteomics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Genomics & Proteomics is 2.60, ranking in quartile Q2 of Web of Science (SCIE).

Is Cancer Genomics & Proteomics indexed in Web of Science or Scopus?

Yes, Cancer Genomics & Proteomics is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.807 (Q2) and an H-index of 53.

Who publishes Cancer Genomics & Proteomics and what is the Article Processing Charge (APC)?

Cancer Genomics & Proteomics is published by International Institute of Anticancer Research. The estimated Article Processing Charge (APC) is approximately $3,139 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Genomics & Proteomics?

The official ISO-4 abbreviation of Cancer Genomics & Proteomics is "CANCER GENOM PROTEOM". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #6,823Hybrid

Cancer Genomics & Proteomics

Abbreviation (ISO):CANCER GENOM PROTEOM

•

Identifier (ISSN):1109-6535(Print)/1790-6245(Online)

•

Publisher:International Institute of Anticancer Research

Official Website Submission Portal Compare

Clarivate IF (2026)

2.6– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Genomics & Proteomics

WoS Q2

Annual Impact Factor Metric

Current (2026):2.6

Scopus SJR & RankScopus Q2

0.807

#6,823

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

53 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate11.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

61articles/year

99.5% Gold OA•89.47% Original Research

Aims & Scope

Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004. Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research. From January 2013 CGP is converted to an online-only open access journal. Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.

Topics Covered (Recognized by AI)

Biology99.3%Genetics98.1%Medicine93.9%Chemistry93.3%Biochemistry91.9%Internal medicine85.4%Gene79%Cancer research67.5%Cancer67.2%Pathology44.4%Cell biology33.1%Oncology31.1%Immunology29.6%Gene expression25%Molecular biology23.8%

Primary Research Areas

Oncology Genetics & Heredity

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

GENETICS & HEREDITY

Rank96/192

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank196/333

IndexSCIE

JCISCIE2026

GENETICS & HEREDITY

Rank93/192

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank151/333

IndexSCIE

Category	Index	Rank	Quartile
GENETICS & HEREDITY	JCRSCIE	96/192	Q2
ONCOLOGY	JCRSCIE	196/333	Q3
GENETICS & HEREDITY	JCISCIE	93/192	Q2
ONCOLOGY	JCISCIE	151/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.6

Articles / Year60

Total Citations14

2025

IF2.6

Articles / Year63

Total Citations114

2024

IF2.6

Articles / Year60

Total Citations224

2023

IF2.5

Articles / Year66

Total Citations438

2022

IF3.395

Articles / Year60

Total Citations660

Year	Impact Factor	Articles / Year	Total Citations
2026	2.6	60	14
2025	2.6	63	114
2024	2.6	60	224
2023	2.5	66	438
2022	3.395	60	660
2021	4.069	71	995
2020	3.28	66	1,007
2019	3.147	55	1,216
2018	2.432	56	2,988
2017	—	46	1,572
2016	—	11	294
2006	—	4	43

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,823Scopus Q2SCImago Profile

Scopus Coverage:2004-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.807

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.66

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,139 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations533

3-Year Documents183

Citable Documents183

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate35.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2

GeneticsQ2

Medicine (miscellaneous)Q2

Cancer ResearchQ3

Molecular BiologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 11.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Genomics & Proteomics (abbr: CANCER GENOM PROTEOM, ISSN: 1109-6535) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by International Institute of Anticancer Research in Greece. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.807 (Q2), an H-index of 53.

The journal enforces rigorous peer evaluation with an annual output of approximately 61 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,139 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.